(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
New peace laureate: Iran's arrest of Mohammadi 'confession of fear' - 2Reality TV star Spencer Pratt, who lost his home in Palisades Fire, is running for mayor of Los Angeles
- 3Novo and Lilly cut prices of weight-loss drugs in China
- 4Fundamental Archives for Beginning Your Business
- 5Egypt's cafés and shops forced to close early due to Iran war
- Evidence of lost baptismal rite stage uncovered in Byzantine era cathedral near Sea of Galilee
- Top Music and Dance Celebration: Which One Gets You Going?
- A rare whale is having an encouraging season for births. Scientists warn it might still go extinct
- Dolly Parton misses Dollywood event due to 'a few health challenges' after skipping honorary Oscars
- The Appearance of Experience: Embracing the Reduced Portage Horse
- Ukraine apologizes to Finland for crashed drones
- Share your pick for the riding area that characterizes your surf undertakings!
- Boeing's troubled capsule won't carry astronauts on next space station flight
- Netflix's 'Lord of the Flies' show blends 'Adolescence' and 'Yellowjackets'
